Pharmacological analysis of 5-hydroxytryptamine receptors in isolated intracranial and extracranial vessels of cat and man.
D000818:Animals; D001158:Arteries / Q000294:innervation*; D002415:Cats; D002536:Cerebral Arteries / Q000294:innervation*; D004305:Dose-Response Relationship, Drug; D004983:Ethanolamines / Q000494:pharmacology; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011460:Prostaglandins F / Q000494:pharmacology; D011985:Receptors, Serotonin / Q000187:drug effects*; D012701:Serotonin / Q000494:pharmacology; D014363:Tryptamines / Q000494:pharmacology; D014661:Vasoconstriction / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects
D004983:Ethanolamines; D011460:Prostaglandins F; D011985:Receptors, Serotonin; D014363:Tryptamines; D010643:Phenoxybenzamine; D012701:Serotonin; D008238:Lysergic Acid Diethylamide; D011433:Propranolol; D008784:Methysergide; D010646:Phentolamine